Small-Molecule Chemical Knockdown of MuRF1 in Melanoma Bearing Mice Attenuates Tumor Cachexia Associated Myopathy

Patients with malignant tumors frequently suffer during disease progression from a syndrome referred to as cancer cachexia (CaCax): CaCax includes skeletal muscle atrophy and weakness, loss of bodyweight, and fat tissues. Currently, there are no FDA (Food and Drug Administration) approved treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Adams, Volker, Gußen, Victoria, Zozulya, Sergey, Cruz, André, Moriscot, Anselmo, Linke, Axel, Labeit, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600862/
https://www.ncbi.nlm.nih.gov/pubmed/33050629
http://dx.doi.org/10.3390/cells9102272

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600862/
https://www.ncbi.nlm.nih.gov/pubmed/33050629
http://dx.doi.org/10.3390/cells9102272

Ejemplares similares